<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-20T11:34:51+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>卫材拳头品种仑伐替尼大卖；国内7家仿制药申请</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/AeIv4iszjFU6Acb4_Q_W2w</id>
    <link href="https://mp.weixin.qq.com/s/AeIv4iszjFU6Acb4_Q_W2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开启细胞疗法前景价值的三个关键</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/SM6tmMwUgZAge7MJboujDQ</id>
    <link href="https://mp.weixin.qq.com/s/SM6tmMwUgZAge7MJboujDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【视频回顾】祝贺中国新药创新者大会圆满落幕！精彩大放送</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/tknvJ-b5Mb0E4M9ZXlTkFQ</id>
    <link href="https://mp.weixin.qq.com/s/tknvJ-b5Mb0E4M9ZXlTkFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】先声药业1类新药注射用trilaciclib临床试验申请获受理；科伦药业注射用帕瑞昔布钠通过仿制药一致性评价...</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/9JWFIWEf8RQTmmooCV1E9A</id>
    <link href="https://mp.weixin.qq.com/s/9JWFIWEf8RQTmmooCV1E9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>贝达药业1类新药盐酸恩沙替尼获批！</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/XjZGUi25YEl_dveRjtfSuw</id>
    <link href="https://mp.weixin.qq.com/s/XjZGUi25YEl_dveRjtfSuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>@医药人，这场石家庄免费制剂技术会议就差你了（内含参会名单）</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/gFO_fAUXG-Z_4vB8liUqGQ</id>
    <link href="https://mp.weixin.qq.com/s/gFO_fAUXG-Z_4vB8liUqGQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>开发遗传性血管性水肿新药，Pharvaris完成超额8000万美元C轮融资</title>
    <updated>2020-11-19T20:35:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/_YQCA_DUpjd_809CX5oV_A</id>
    <link href="https://mp.weixin.qq.com/s/_YQCA_DUpjd_809CX5oV_A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>自免大品种：恒瑞IL-17领先，进3期临床已投入1.7亿</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/b6YQS53xXHFG3rVRHy3HNg</id>
    <link href="https://mp.weixin.qq.com/s/b6YQS53xXHFG3rVRHy3HNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>丽珠集团罕见病药物获批，阳光德美助力丹曲林钠研发</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/jci4WEkuQVMe3IUExfsOSw</id>
    <link href="https://mp.weixin.qq.com/s/jci4WEkuQVMe3IUExfsOSw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿美乐：精准治疗 让希望同行</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/L3vNJtvfe397AUjd8NX-kg</id>
    <link href="https://mp.weixin.qq.com/s/L3vNJtvfe397AUjd8NX-kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>@医药人，这场石家庄免费制剂技术会议就差你了（内含参会名单）</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/JQ_b1c-5zP0zAVnPqZ2bew</id>
    <link href="https://mp.weixin.qq.com/s/JQ_b1c-5zP0zAVnPqZ2bew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|药明系持股近30%，德昇济医药完成2亿美元A轮融资</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/BYp04G-Fp-6eYlRDI015iw</id>
    <link href="https://mp.weixin.qq.com/s/BYp04G-Fp-6eYlRDI015iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】浙江医药创新药稳步推进，维生素盈利向好；鲁抗医药子公司收到盐酸氨溴索注射液《药品注册证书》  ​...</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/SfFbwPdUtFh47k7z2KokcQ</id>
    <link href="https://mp.weixin.qq.com/s/SfFbwPdUtFh47k7z2KokcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海南海药：与上药所合作共建神经精神疾病药物联合实验室，促进我国神经精神药物创新</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/Bm69EGWfjR_XRxy-Yp3Dmg</id>
    <link href="https://mp.weixin.qq.com/s/Bm69EGWfjR_XRxy-Yp3Dmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>即将终结亚力兄C5单抗独霸时代，补体C3抑制剂上市申请获优先审查</title>
    <updated>2020-11-19T00:23:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/W92w4N3nGCPCckpFVuluhw</id>
    <link href="https://mp.weixin.qq.com/s/W92w4N3nGCPCckpFVuluhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IgA肾病患者福音：布地奈德改良新药即将NDA</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/lliDqm6Uc6uYo8BvJ5IQag</id>
    <link href="https://mp.weixin.qq.com/s/lliDqm6Uc6uYo8BvJ5IQag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海思科：研发投入每年8亿，创新药进入收获期</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/XBLTqeDkGAEgo3rkZPE47Q</id>
    <link href="https://mp.weixin.qq.com/s/XBLTqeDkGAEgo3rkZPE47Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新CRO服务&amp;化药制剂两翼齐飞——亚太药业</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/raOI0yX3IxE0XVqoSZ_yoQ</id>
    <link href="https://mp.weixin.qq.com/s/raOI0yX3IxE0XVqoSZ_yoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】片仔癀：主动撤回“PZH2109胶囊”临床试验注册申请；恒瑞医药SHR-1314注射液获批临床试验</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/4ouZH700tTs0zLPV2ke7BA</id>
    <link href="https://mp.weixin.qq.com/s/4ouZH700tTs0zLPV2ke7BA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>海辰药业：抗肿瘤药物“NMS-03305293 胶囊”获批药物临床试验</title>
    <updated>2020-11-17T18:11:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/mrhRN1QXmpruj6jyKqZclA</id>
    <link href="https://mp.weixin.qq.com/s/mrhRN1QXmpruj6jyKqZclA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>